Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Omaha, Nebraska 68131


Purpose:

We are studying Xolair (omalizumab) to see it's effect on allergic blood cells. The blood tests will be done in a test tube to see if they react differently before and after treatment. The blood cells will be mixed with to whatever the person is allergic.


Study summary:

Must be allergic-asthma with IgE between 30 and 700 IU/ml.


Criteria:

Inclusion Criteria: - 2 year history of ragweed allergic rhinitis - positive skin prick tests to ragweed >5 mm wheal diameter - serum IgE <700 iU/m Exclusion Criteria: - Use of prohibited medications (e.g. antihistamine in past 7 days and topical or oral corticosteroids in past 1 month, beta-agonist or theophylline for 1 week - History of immunotherapy in the past 2 years - Exposure to Omalizumab in the past 2 years - Clinically significant non-allergic or perennial rhinitis to avoid mediator release due to environmental allergens - Asthma other than mild intermittent - Women of childbearing potential who are not on an accepted form of birth control, as well as women who are breastfeeding - Known sensitivity to study drug Xolair - Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study - Patients with a previous history of cancer - Use of any other investigational agent in the last 30 days


NCT ID:

NCT00657891


Primary Contact:

Principal Investigator
Robert G Townley, MD
Creighton University


Backup Contact:

N/A


Location Contact:

Omaha, Nebraska 68131
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.